FAP inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9346814
APP PUB NO 20140357650A1
SERIAL NO

14372798

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel inhibitors having high selectivity and specificity for FAP (fibroblast activation protein). Said inhibitors are useful as a human and/or veterinary medicine, in particular for the treatment and/or prevention of FAP-related disorders such as but not limited to proliferative disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER333 COTTMAN AVENUE SUITE P2179 PHILADELPHIA PA 19111

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Augustyns, Koen Wilrijk, BE 12 22
Cheng, Jonathan D Philadelphia, US 1 12
De, Meester Ingrid Wilrijk, BE 1 12
Heirbaut, Leen Wilrijk, BE 1 12
Jansen, Koen Wilrijk, BE 1 12
Joossens, Jurgen Wilrijk, BE 10 20
Van, Der Veken Pieter Wilrijk, BE 13 25

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 24, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00